Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease
Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company addressing neurodegenerative […]
Spartha Medical Receives €2.4M in Financing from European Innovation Council
Spartha Medical, a French medtech company specialized in developing multifunctional antimicrobial, antiviral and anti-inflammatory coatings, […]
H.E.L Group Appoints Rajeev Kumria as General Manager of H.E.L India
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, […]
Cytovation Raises $20 Million in Series A Financing Round to Advance Clinical Development of CyPep-1, a First-in-Class Targeted Tumor Membrane Immunotherapy
Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted […]
Roche’s Evrysdi (risdiplam) Granted FDA Priority Review for Treatment of Pre-symptomatic Babies Under 2 Months of Age with Spinal Muscular Atrophy (SMA)
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration […]
Amniotics Strengthens its Clinical and Regulatory Capabilities
Amniotics AB (publ) (Nasdaq Stockholm: AMNI), a developer of novel cell therapy products, has appointed […]
Research Demonstrates Novel HIT Receptor Enhances T Cell Antigen Sensitivity and Elicits Superior Tumor Control
The journal Nature Medicine recently published a study in which researchers developed a novel receptor to enhance […]
Freenome Presents Research Highlighting its Multiomics Blood Testing Platform in PREEMPT CRC
Freenome, a privately held biotech company, presented at the American Society of Clinical Oncology Gastrointestinal […]
TFS HealthScience Appoints Eva Brike as Chief People Officer
TFS HealthScience, a global mid-size CRO, announced that Eva Brike has joined the company as […]
FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High Risk for COVID-19 Disease Progression
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more